Longevity & Aging · Metabolic & Cardiometabolic
high dietary protein leucine causes atherosclerosis via macrophage mTORC1 activation
In plain terms: Does eating a lot of protein clog arteries through a leucine/mTOR pathway?
Contested Longevity & Aging 🔬 Includes disconfirming
Part of: • ApoB & Lipid Longevity
RefutedContestedStrong support
consensus score -0.15
Real, well-characterized mechanism with a leucine threshold and some human monocyte/macrophage data — but the atherosclerosis outcome itself is shown only in mice; there is NO human cardiovascular-endpoint trial.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
3 support 2 contradict 3 tested null 3 mixed · 11 sources, 5 independent groups
What the evidence shows
The mechanism is real and well characterised, with a dose-dependent leucine threshold activating mTORC1 in human monocytes and macrophages and promoting atherosclerosis in animals. Human outcome data do not follow: a 13-year African cohort found higher animal protein associated with lower risk, and macronutrient associations in women's cohorts were weak.
The evidence (18)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Inao T, Ito YM, Yokota T, Fukushima A, Ono T, Sota T, Kinugasa Y, Takahashi M, Matsukawa R, Yoshida I, Kakinoki S, Yonezawa K, Himura Y, Yokota I, Yamamoto K, Tsuchihashi-Makaya M, Kinugawa S 2026 · Clin Nutr ESPEN | observational | mixed | low | Cohort of chronic heart failure patients found animal vs plant protein intakes had differing associations with mortality/hospitalization, a diseased HF population not testing atherosclerosis onset. |
| Zhang X, Ajam A, Liu Z, Peroumal D, Khan SR, Razani B 2025 · Autophagy | animal | supports | moderate | Follow-up confirms dose-dependent leucine-mTOR threshold in human monocytes/macrophages and atherosclerosis acceleration in mice; frames therapeutic target — still no human clinical endpoint. |
| Linde M, Van der Merwe C, Ricci C, Pieters M 2026 · Br J Nutr | observational | contradicts | moderate | Prospective African cohort (1737 adults, 13y) found higher animal protein intake associated with LOWER all-cause mortality and no significant association with CVD mortality. |
| Gribbin S, Enticott J, Hodge AM, Moran L, Thong E, Joham A, Zaman S 2022 · Heart | observational | tested-null | moderate | Australian women's cohort found dietary macronutrient (including protein) associations with CVD were inconsistent/weak, a null-to-mixed cohort data point on protein and cardiovascular disease. |
| Bonacina F, Zhang X, Manel N, Yvan-Charvet L, Razani B, Norata GD 2025 · Nature reviews. Cardiology | mechanism | supports | high | Nature Reviews Cardiology narrative review of lysosomal nutrient sensing in atherosclerosis. Only claim-relevant line cites prior work: 'macrophage mTORC1 is activated by dietary amino acids and mediates high protein diet-induced atherogenesis through the inhibition of lysosomal autophagy' (ref 168). No own data — review, zero weight. |
| Starling-Soares B, Coelho MM, Campolina BG, Duarte CK, Maioli TU 2026 · Obesity reviews : an official journal of the International Association for the Study of Obesity | mechanism | mixed | moderate | Narrative review, not evidence: 'our aim in this narrative review is to describe and present the relation between BCAA and inflammation in the obesity and diabetes context.' 'our current knowledge cannot identify a causative role for these amino acids'. No atherosclerosis endpoint. Review — zero weight. |
| Yang X, Shi J, He W, Li J, Li R, Pi J, Luo Y, Gu M, Wang X, Wu W, Qing L 2024 · Am J Chin Med | animal | supports | low | ApoE-/- mouse study showed enhancing autophagy by inhibiting PI3K/Akt/mTOR reduced atherosclerotic lipid accumulation, corroborating the mTOR-autophagy axis mechanistically (pharmacologic, not protein). |
| Paik JK, Park M, Shin JE, Jang SY, Shin JY 2020 · Nutrients | observational | mixed | moderate | Korean prospective cohort found high protein-to-carbohydrate ratio associated with increased metabolic syndrome/triglycerides/fasting glucose in men only, an indirect cardiometabolic signal not atherosclerosis per se. |
| Wang Y, Liao Q, Mei X, Xu H, Luo L, Huang R, Tang Y, Zhou C 2025 · PLoS One | animal | tested-null | low | In ApoE-/- mice suppressing the PI3K/Akt/mTOR pathway reduced atherosclerotic plaque, supporting macrophage mTOR as atherogenic but via drug inhibition, not dietary leucine. |
| Müller JS, van der Vorst EPC 2026 · Cell Communication and Signaling : CCS | animal | supports | moderate | Systematic review of 162 publications/76 kinases in macrophage atherogenesis; its protein-intake passage is a narrative re-summary of a single already-counted primary study (ref [366] = Zhang 2024, Nat Metab, PMID 38409323 / s38409323), not independent data: 'Notably, leucine, above a certain dietary threshold, activated mTORC1 in human monocytes/macrophages, thereby increasing the risk of atherosclerotic progression [366].' 'High protein intake, compared with low protein intake, led to elevated plasma amino acids and mTORC1 activation shortly after a meal, along with decreased autophagy marker LC3.' 'Increasing dietary protein produced a dose-dependent increase in mTOR activation in plaque macrophages, accompanied by increased plaque size, necrotic core area, macrophage numbers, and apoptosis [366].' Every sentence in the passage cites [366]; this review contributes no observation the vault does not already hold through s38409323 and is zero-weighted (evidence_role: review) to avoid double-counting the same primary study. |
| Li J, Chen H, Zhou Y, Sun L, Xing Y, Sun Y, Yang Y, Shi Y 2026 · Frontiers in immunology | observational | mixed | moderate | Review of BCAA/leucine-mTORC1 signaling in chronic disease including CVD, human evidence framed as 'accumulating association' not causal proof, no atherosclerosis-specific numbers given. |
| Mantzouranis E, Kakargia E, Kakargias F, Lazaros G, Tsioufis K 2023 · Nutrients | meta-analysis | contradicts | moderate | Meta-analysis of 14 prospective cohorts found no significant association between high vs normal protein intake and cardiovascular mortality or events in adults without CVD. |
| Song M, Fung TT, Hu FB, Willett WC, Longo VD, Chan AT, Giovannucci EL 2016 · JAMA Intern Med | observational | mixed | high | Two large US cohorts found higher animal protein associated with modestly higher CVD mortality mainly among people with lifestyle risk factors, while plant protein was inversely associated. |
| Bell HL, Jackson KG, Crompton LA, Givens DI, Lovegrove JA 2025 · Nutr Res Rev | mechanism | mixed | moderate | Narrative review, no pooling: 'This narrative review used a systematic search approach with relevant keywords to identify evidence from randomised controlled trials ... on the effects of WP intake on plasma BCAA and glycaemic control.' Endpoints are BCAA and glycaemia only (6 acute studies: WP 'significantly elevates postprandial BCAA and insulin responses'; 3 chronic: 'inconsistent findings'); atherosclerosis and macrophage mTORC1 are not measured. Review — zero weight. |
| Jankovic N, Geelen A, Streppel MT, de Groot LC, Kiefte-de Jong JC, Orfanos P, Bamia C, Trichopoulou A, Boffetta P, Bobak M, Pikhart H, Kee F, O'Doherty MG, Buckland G, Woodside J, Franco OH, Ikram MA, Struijk EA, Pajak A, Malyutina S, Kubinova R, Wennberg M, Park Y, Bueno-de-Mesquita HB, Kampman E, Feskens EJ 2015 · Am J Clin Nutr | observational | tested-null | moderate | Pooled analysis of elderly European/US cohorts found adherence to WHO protein targets was not clearly related to CVD mortality, no cohort signal that high protein drives cardiovascular death in older adults. |
| Zhang X, Kapoor D, Jeong SJ, Fappi A, Stitham J, Shabrish V, Sergin I, Yousif E, Rodriguez-Velez A, Yeh YS, Park A, Yurdagul A, Rom O, Epelman S, Schilling JD, Sardiello M, Diwan A, Cho J, Stitziel NO, Javaheri A, Lodhi IJ, Mittendorfer B, Razani B 2024 · Nat Metab | animal | supports | high | Human feeding studies show leucine activates macrophage mTOR above about 25g protein/meal; atherosclerosis itself demonstrated in mice fed greater than about 22% energy as protein — mechanism human, hard outcome murine. |
| Wu Y, Avcilar-Kücükgöze I, Santovito D, Atzler D 2024 · Biomolecules | observational | mixed | moderate | Review focused specifically on L-leucine, L-arginine, L-glutamine regulating autophagy in atherogenesis via amino-acid-sensing pathways (mTORC1 is the master amino-acid sensor for autophagy); entirely mechanistic/cell-biology synthesis, no |
| Shen R, Zhang Y 2025 · International journal of molecular medicine | observational | supports | low | Review states 'elevated BCAA levels are associated with atherosclerosis development' via immunometabolic reprogramming affecting macrophages/T/B cells in coronary heart disease; draws on animal and human observational data but reports no sp |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.